Alzamend Neuro reported total assets of $0.01B and total liabilities of $0.00B for the quarter ended Jul 2026, up 35.0% year over year. This balance sheet covers 26 quarters of results from Apr 2020 through Jul 2026, standardized by Business Quant from the company’s SEC filings.
| Balance SheetBalance Sheet | Apr2020 | Jul2020 | Oct2020 | Jan2021 | Apr2021 | Jul2021 | Oct2021 | Jan2022 | Apr2022 | Jul2022 | Oct2022 | Jan2023 | Apr2023 | Jul2023 | Oct2023 | Jan2024 | Apr2024 | Jul2024 | Oct2024 | Jan2025 | Apr2025 | Jul2025 | Oct2025 | Jan2026 | Apr2026 | Jul2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||||||||
| Current Assets | ||||||||||||||||||||||||||
| Cash & EquivalentsCash & Equiv. | 13.57M | 11.79M | 14.06M | 11.53M | 9.18M | 7.38M | 5.14M | 1.70M | 0.20M | 0.28M | 0.38M | 1.19M | 4.09M | 3.36M | 3.95M | 5.62M | 4.45M | 2.71M | 0.71M | 7.59M | ||||||
| Short-term InvestmentsInvestments (Current) | 13,556.00M | |||||||||||||||||||||||||
| Cash & Current Investments | 13.57M | 11.79M | 14.06M | 11.53M | 9.18M | 7.38M | 5.14M | 1.70M | 0.20M | 13,556.28M | 0.38M | 1.19M | 4.09M | 3.36M | 3.95M | 5.62M | 4.45M | 2.71M | 0.71M | 7.59M | ||||||
| Receivables - OtherOther Receivables | 0.02M | -14.88M | -14.88M | 0.01M | -14.88M | -14.88M | -14.88M | -14.88M | -14.88M | 70,000.00M | ||||||||||||||||
| Current Deferred Tax AssetsCurrent Deferred Tax | -10.08M | -10.81M | -15.77M | -15.25M | -15.40M | |||||||||||||||||||||
| Prepaid Assets | 0.93M | 0.64M | 0.35M | 0.59M | 0.74M | 0.55M | 0.45M | 0.72M | 0.58M | 0.31M | 0.08M | 0.22M | 0.67M | 0.59M | 0.23M | 0.31M | 0.27M | 0.99M | 1.05M | 0.66M | ||||||
| Current Assets | 14.50M | 12.43M | 14.41M | 12.11M | 10.33M | 8.42M | 5.84M | 2.41M | 0.78M | 0.59M | 0.46M | 1.42M | 4.77M | 3.95M | 4.18M | 5.93M | 4.72M | 3.70M | 1.76M | 8.25M | ||||||
| Non-Current Assets | ||||||||||||||||||||||||||
| Property, Plant & Equipment (Net)PP&E (Net) | 0.10M | 0.10M | 0.09M | 0.09M | 0.08M | 0.21M | 0.20M | 0.19M | 0.18M | 0.25M | 0.24M | 0.23M | 0.43M | 0.40M | 0.37M | 0.34M | 0.31M | 0.29M | ||||||||
| Long-Term Investments | 1,360,000.00M | 1,360,000.00M | 1,360,000.00M | 1,360,000.00M | 1,360,000.00M | 3,000.00M | 3,000.00M | 3,000.00M | 3,000.00M | 6,000.00M | 6,000.00M | |||||||||||||||
| Goodwill | 6.37M | 6.47M | ||||||||||||||||||||||||
| Goodwill & Intangibles | 6.37M | 6.47M | ||||||||||||||||||||||||
| Long-Term Deferred Tax | 10.10M | 10.83M | 15.80M | 15.27M | 15.41M | |||||||||||||||||||||
| Non-Current Assets | 0.10M | 0.10M | 0.09M | 0.09M | 0.08M | 0.21M | 0.20M | 0.19M | 0.18M | 0.25M | 0.24M | 0.23M | 0.43M | 0.40M | 0.37M | 0.34M | 0.31M | 0.29M | ||||||||
| Assets | 14.50M | 12.43M | 14.52M | 12.21M | 10.42M | 8.50M | 5.92M | 2.63M | 0.98M | 0.78M | 0.63M | 1.67M | 5.01M | 4.18M | 4.60M | 6.33M | 5.09M | 4.04M | 2.08M | 8.54M | ||||||
| Liabilities | ||||||||||||||||||||||||||
| Current Liabilities | ||||||||||||||||||||||||||
| Accounts Payables | 1.13M | 0.46M | 1.16M | 1.03M | 0.65M | 2.64M | 2.87M | 2.74M | 3.67M | 3.83M | 2.93M | 2.88M | 1.25M | 0.73M | 0.63M | 0.98M | 0.72M | 1.86M | 1.35M | 2.74M | ||||||
| Notes Payables | 0.30M | |||||||||||||||||||||||||
| Payables | 1.13M | 0.46M | 1.16M | 1.03M | 0.65M | 2.64M | 2.87M | 2.74M | 3.67M | 3.83M | 3.23M | 2.88M | 1.25M | 0.73M | 0.63M | 0.98M | 0.72M | 1.86M | 1.35M | 2.74M | ||||||
| Accumulated Expenses | 0.24M | 0.00M | ||||||||||||||||||||||||
| Other Accumulated Expenses | 0.00M | 0.00M | 0.00M | 0.99M | 0.01M | |||||||||||||||||||||
| Total Current Liabilities | 1.48M | 0.47M | 1.16M | 1.03M | 1.64M | 2.64M | 2.87M | 2.74M | 3.67M | 3.83M | 3.23M | 2.88M | 1.25M | 0.73M | 0.63M | 0.98M | 0.72M | 1.86M | 1.35M | 2.74M | ||||||
| Non-Current Liabilities | ||||||||||||||||||||||||||
| Convertible Debt | 0.34M | |||||||||||||||||||||||||
| Preferred Stock Liabilities | 75.00 | 0.48M | ||||||||||||||||||||||||
| Other Non-Current Liabilities | 8.83M | 10.15M | 2.28M | 0.74M | 2.64M | 2.68M | 1.08M | |||||||||||||||||||
| Total Non-Current Liabilities | -8.36M | -9.12M | 0.59M | 4.30M | 0.59M | -2.04M | 0.26M | |||||||||||||||||||
| Total Liabilities | 1.48M | 0.47M | 1.16M | 1.03M | 1.64M | 2.64M | 2.87M | 2.74M | 3.67M | 5.05M | 3.23M | 2.88M | 1.25M | 0.73M | 0.63M | 0.98M | 0.72M | 1.84M | 1.35M | 2.74M | ||||||
| Shareholder's Equity | ||||||||||||||||||||||||||
| Total Debt | 0.30M | |||||||||||||||||||||||||
| Common Equity | 13.03M | 11.96M | 13.35M | 11.18M | 8.79M | 5.86M | 3.05M | -0.11M | -2.68M | -4.26M | -2.59M | -1.21M | 3.75M | 3.45M | 3.97M | 5.34M | 4.37M | 2.20M | 0.73M | 5.80M | ||||||
| Liabilities and Shareholders Equity | 14.50M | 12.43M | 14.52M | 12.21M | 10.42M | 8.50M | 5.92M | 2.63M | 0.98M | 0.78M | 0.63M | 1.67M | 5.01M | 4.18M | 4.60M | 6.33M | 5.09M | 4.04M | 2.08M | 8.54M | ||||||
| Retained Earnings | -22.75M | -25.33M | -29.19M | -32.23M | -35.34M | -40.77M | -44.07M | -47.60M | -50.51M | -53.17M | -54.02M | -54.99M | -56.41M | -57.40M | -58.54M | -61.24M | -62.24M | -64.44M | -67.31M | -70.33M | ||||||
| Preferred Shares | 0.00 | 75.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 |
Pull Alzamend Neuro's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=ALZN&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "ALZN", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=ALZN&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();